The effect of antimalarial drugs on the exoerythrocytic and erythrocytic stages of blood-induced infections of Plasmodium fallax in the Turkey
Identifieur interne : 003F22 ( Main/Exploration ); précédent : 003F21; suivant : 003F23The effect of antimalarial drugs on the exoerythrocytic and erythrocytic stages of blood-induced infections of Plasmodium fallax in the Turkey
Auteurs : Richard N. Rossan [États-Unis]Source :
- Experimental Parasitology [ 0014-4894 ] ; 1957.
English descriptors
- Teeft :
- Antimalarial, Antimalarial drugs, Blood cells, Blood smears, Blood stages, Brain smear, Brain smears, Chemotherapy, Chick, Chlorguanide, Chloroquine, Coatney, Control birds, Daily accumulative percentage, Daily counts, Dosage, Drug regimen, Erythrocyte, Erythrocytic parasites, Exoerythrocytes, Exoerythrocytic, Exoerythrocytic forms, Exoerythrocytic segmenters, Exoerythrocytic stages, Fallax, Gallinaceum, General trend, High dosage, High parasitemia, Inoculation, Isopentaquine, Malarial, Pamaquine, Parasite, Parasitemia, Patent parasitemia, Peak parasitemia, Pentaquine, Plasmodia exoerythrocytes, Plasmodium, Plasmodium fallax, Plasmodium gallinaceum, Primaquine, Pyrimethamine, Quinacrine, Quinine, Quinine therapy, Regimen, Rossan, Same time, Smear, Sulfadiazine, Sulfadiazine regimen, Supplementary test series, Test series, Tissue sections, Untreated birds.
Abstract
Abstract: 1.1. The parasite-host combination of Plasmodium fallax in the turkey is ideally suited for chemotherapeutic studies. The course of parasitemia following blood inoculation is of a consistently reproducible nature. Exoerythrocytic stages are invariably produced from the blood stages at a specific time during the infection, with the ensuing death of the host. Spontaneous recovery is unknown in this host-parasite combination.2.2. A minimal length of time (approximately 13 days) appears to be required for the appearance of the exoerythrocytic segmenters in the tissues. This is true regardless of whether there has been a patent parasitemia.3.3. In the routine testing of the drugs at low dosage, no drug was capable of significantly decreasing the peak parasitemia as compared with that of the controls. In a supplementary test series, sulfadiazine was able to decrease the peak parasitemia significantly. However, the drug was being used near the toxic level for turkeys.4.4. When the drugs were used at higher dosages sulfadiazine had the greatest effect of delaying the peak parasitemia, while quinacrine cleared the blood of parasites faster than any other drug. Parasitemia was suppressed for the longest time under the isopentaquine regimen, and under the same regimen the mean length of time before death was increased.5.5. A greater immune response was elicited in the controls than in the birds treated with high dosages of drugs against subsequent reinvasion of the erythrocytes by the merozoites produced from the exoerythrocytic segmenters. Immunity appeared to be definitely lower when the antigen (the erythrocytic parasites) was removed by treatment.6.6. In the routine testing procedures, there was an indication that the 8-aminoquinolines (pamaquine, pentaquine, and isopentaquine) were able to prevent, or at least delay, formation of the exoerythrocytic stages.7.7. Special regimens of treatment with sulfadiazine and pyrimethathine showed that pyrimethamine was far more effective than sulfadiazine in inhibiting the formation of the exoerythrocytic stages.8.8. The prime requisite for curing blood-induced P. fallax infections in the turkey was found to be the killing of or the prevention of the formation of the exoerythrocytic stages.
Url:
DOI: 10.1016/0014-4894(57)90013-9
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001166
- to stream Istex, to step Curation: 001166
- to stream Istex, to step Checkpoint: 002C38
- to stream Main, to step Merge: 004010
- to stream Main, to step Curation: 003F22
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>The effect of antimalarial drugs on the exoerythrocytic and erythrocytic stages of blood-induced infections of Plasmodium fallax in the Turkey</title>
<author><name sortKey="Rossan, Richard N" sort="Rossan, Richard N" uniqKey="Rossan R" first="Richard N." last="Rossan">Richard N. Rossan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1D29A62BEF1CC7D843CED768FB831DF23EA21A74</idno>
<date when="1957" year="1957">1957</date>
<idno type="doi">10.1016/0014-4894(57)90013-9</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-5SSCBKDW-D/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001166</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001166</idno>
<idno type="wicri:Area/Istex/Curation">001166</idno>
<idno type="wicri:Area/Istex/Checkpoint">002C38</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002C38</idno>
<idno type="wicri:doubleKey">0014-4894:1957:Rossan R:the:effect:of</idno>
<idno type="wicri:Area/Main/Merge">004010</idno>
<idno type="wicri:Area/Main/Curation">003F22</idno>
<idno type="wicri:Area/Main/Exploration">003F22</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">The effect of antimalarial drugs on the exoerythrocytic and erythrocytic stages of blood-induced infections of Plasmodium fallax in the Turkey</title>
<author><name sortKey="Rossan, Richard N" sort="Rossan, Richard N" uniqKey="Rossan R" first="Richard N." last="Rossan">Richard N. Rossan</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Naval Medical Research Institute, National Naval Medical Center, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Experimental Parasitology</title>
<title level="j" type="abbrev">YEXPR</title>
<idno type="ISSN">0014-4894</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1957">1957</date>
<biblScope unit="volume">6</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="163">163</biblScope>
<biblScope unit="page" to="188">188</biblScope>
</imprint>
<idno type="ISSN">0014-4894</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0014-4894</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Antimalarial</term>
<term>Antimalarial drugs</term>
<term>Blood cells</term>
<term>Blood smears</term>
<term>Blood stages</term>
<term>Brain smear</term>
<term>Brain smears</term>
<term>Chemotherapy</term>
<term>Chick</term>
<term>Chlorguanide</term>
<term>Chloroquine</term>
<term>Coatney</term>
<term>Control birds</term>
<term>Daily accumulative percentage</term>
<term>Daily counts</term>
<term>Dosage</term>
<term>Drug regimen</term>
<term>Erythrocyte</term>
<term>Erythrocytic parasites</term>
<term>Exoerythrocytes</term>
<term>Exoerythrocytic</term>
<term>Exoerythrocytic forms</term>
<term>Exoerythrocytic segmenters</term>
<term>Exoerythrocytic stages</term>
<term>Fallax</term>
<term>Gallinaceum</term>
<term>General trend</term>
<term>High dosage</term>
<term>High parasitemia</term>
<term>Inoculation</term>
<term>Isopentaquine</term>
<term>Malarial</term>
<term>Pamaquine</term>
<term>Parasite</term>
<term>Parasitemia</term>
<term>Patent parasitemia</term>
<term>Peak parasitemia</term>
<term>Pentaquine</term>
<term>Plasmodia exoerythrocytes</term>
<term>Plasmodium</term>
<term>Plasmodium fallax</term>
<term>Plasmodium gallinaceum</term>
<term>Primaquine</term>
<term>Pyrimethamine</term>
<term>Quinacrine</term>
<term>Quinine</term>
<term>Quinine therapy</term>
<term>Regimen</term>
<term>Rossan</term>
<term>Same time</term>
<term>Smear</term>
<term>Sulfadiazine</term>
<term>Sulfadiazine regimen</term>
<term>Supplementary test series</term>
<term>Test series</term>
<term>Tissue sections</term>
<term>Untreated birds</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: 1.1. The parasite-host combination of Plasmodium fallax in the turkey is ideally suited for chemotherapeutic studies. The course of parasitemia following blood inoculation is of a consistently reproducible nature. Exoerythrocytic stages are invariably produced from the blood stages at a specific time during the infection, with the ensuing death of the host. Spontaneous recovery is unknown in this host-parasite combination.2.2. A minimal length of time (approximately 13 days) appears to be required for the appearance of the exoerythrocytic segmenters in the tissues. This is true regardless of whether there has been a patent parasitemia.3.3. In the routine testing of the drugs at low dosage, no drug was capable of significantly decreasing the peak parasitemia as compared with that of the controls. In a supplementary test series, sulfadiazine was able to decrease the peak parasitemia significantly. However, the drug was being used near the toxic level for turkeys.4.4. When the drugs were used at higher dosages sulfadiazine had the greatest effect of delaying the peak parasitemia, while quinacrine cleared the blood of parasites faster than any other drug. Parasitemia was suppressed for the longest time under the isopentaquine regimen, and under the same regimen the mean length of time before death was increased.5.5. A greater immune response was elicited in the controls than in the birds treated with high dosages of drugs against subsequent reinvasion of the erythrocytes by the merozoites produced from the exoerythrocytic segmenters. Immunity appeared to be definitely lower when the antigen (the erythrocytic parasites) was removed by treatment.6.6. In the routine testing procedures, there was an indication that the 8-aminoquinolines (pamaquine, pentaquine, and isopentaquine) were able to prevent, or at least delay, formation of the exoerythrocytic stages.7.7. Special regimens of treatment with sulfadiazine and pyrimethathine showed that pyrimethamine was far more effective than sulfadiazine in inhibiting the formation of the exoerythrocytic stages.8.8. The prime requisite for curing blood-induced P. fallax infections in the turkey was found to be the killing of or the prevention of the formation of the exoerythrocytic stages.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Maryland</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Rossan, Richard N" sort="Rossan, Richard N" uniqKey="Rossan R" first="Richard N." last="Rossan">Richard N. Rossan</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F22 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003F22 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:1D29A62BEF1CC7D843CED768FB831DF23EA21A74 |texte= The effect of antimalarial drugs on the exoerythrocytic and erythrocytic stages of blood-induced infections of Plasmodium fallax in the Turkey }}
This area was generated with Dilib version V0.6.33. |